AI assistant
Protagonist Therapeutics, Inc — Director's Dealing 2017
Sep 13, 2017
31163_dirs_2017-09-12_54f810f9-44ae-4651-b1a0-ac63eee5ba72.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2017-09-12
Reporting Person: Shames Richard S. (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-12 | Common Stock | S | 3687 | $14.3078 | Disposed | 0 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017.
F2: Includes 1,822 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 8, 2017.
F3: The shares were sold at prices ranging from $14.251 to $14.3443. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.